Advocate Group’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Sell
51,194
-5,978
-10% -$1.18M 1.61% 17
2026
Q1
$9.41M Sell
57,172
-4,112
-7% -$712K 1.47% 24
2025
Q4
$10.9M Sell
61,284
-10,898
-15% -$1.82M 1.76% 12
2025
Q3
$11.5M Sell
72,182
-2,810
-4% -$415K 1.89% 12
2025
Q2
$10.6M Sell
74,992
-1,908
-2% -$234K 1.89% 13
2025
Q1
$8.97M Sell
76,900
-3,916
-5% -$505K 1.64% 19
2024
Q4
$10.2M Sell
80,816
-3,549
-4% -$437K 1.91% 11
2024
Q3
$8.79M Buy
84,365
+1,557
+2% +$157K 1.59% 22
2024
Q2
$8.05M Buy
82,808
+1,095
+1% +$104K 1.62% 21
2024
Q1
$7.69M Buy
81,713
+8,311
+11% +$732K 1.53% 23
2023
Q4
$6.84M Sell
73,402
-1,591
-2% -$127K 1.47% 22
2023
Q3
$6.12M Buy
74,993
+1,574
+2% +$137K 1.42% 25
2023
Q2
$6.27M Buy
73,419
+1,895
+3% +$162K 1.38% 27
2023
Q1
$6.28M Sell
71,524
-3,728
-5% -$348K 1.37% 28
2022
Q4
$6.4M Buy
75,252
+3,052
+4% +$260K 1.38% 29
2022
Q3
$5.71M Buy
72,200
+2,321
+3% +$196K 1.41% 27
2022
Q2
$5.32M Buy
+69,879
New +$5.72M 1.24% 35

Other funds holding MS

Advocate Group's MS Position: Q2 2026 in Review

Advocate Group reduced its Morgan Stanley (MS) stake by 10% in Q2 2026, selling an estimated $1.18M and leaving 51,194 shares worth $10.7M. The position accounts for 1.61% of the portfolio, ranked #17.

Advocate Group first reported a position in MS in Q2 2022 and has held it in 17 quarters since. The position peaked at $11.5M in Q3 2025. 1,257 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Advocate Group held 51,194 shares of Morgan Stanley worth $10.7M as of Q2 2026.
  • Advocate Group sold 5,978 Morgan Stanley shares in Q2 2026, an estimated $1.18M.
  • Morgan Stanley made up 1.61% of Advocate Group's portfolio in Q2 2026, its #17 holding.
  • Advocate Group first reported a position in Morgan Stanley in Q2 2022 and has held it in 17 quarters since.
  • Advocate Group's Morgan Stanley position peaked at $11.5M in Q3 2025.
  • 1,257 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.